SCHEMBL24573333

SCHEMBL24573333

Cc1ccc(-c2ccc(COCO)o2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.53
KDM4E B2RXH2 5/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
CYP2C19 P33261 3/20 0.53
CYP1A2 P05177 2/20 0.53
DDAH1 O94760 1/20 0.53
MAPT P10636 8/20 0.46
HPGD P15428 3/20 0.46
CYP2C9 P11712 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
NPSR1 Q6W5P4 1/20 0.42
PKM P14618 5/20 0.42
POLB P06746 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HIF1A Q16665 1/20 0.39
EPAS1 Q99814 1/20 0.39
TP53 P04637 3/20 0.38
ALOX5 P09917 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9538809 0.80 ALDH1A1 (0.62) ALDH1A1KDM4ESMN1; SMN2CYP2C19CYP1A2
SCHEMBL10050008 0.74 ALDH1A1 (0.57) ALDH1A1KDM4ESMN1; SMN2CYP2C19CYP1A2
SCHEMBL14541695 0.73 NQO2 (0.52) ALDH1A1KDM4ESMN1; SMN2CYP2C19CYP1A2
SCHEMBL4343079 0.71 NQO2 (0.53) ALDH1A1KDM4ESMN1; SMN2CYP2C19CYP1A2
SCHEMBL15827525 0.70 ALDH1A1 (0.54) ALDH1A1KDM4ESMN1; SMN2CYP2C19CYP1A2
SCHEMBL15217982 0.69 ALDH1A1 (0.77) ALDH1A1KDM4ESMN1; SMN2CYP2C19CYP1A2
SCHEMBL15213964 0.69 ALDH1A1 (1.00) ALDH1A1KDM4ESMN1; SMN2CYP2C19CYP1A2
P-Xylene SCHEMBL28247604 0.69 ACHE (0.50) ALDH1A1SMN1; SMN2LMNA
SCHEMBL8233351 0.68 AGXT (0.54) ALDH1A1KDM4ESMN1; SMN2CYP2C19CYP1A2
SCHEMBL13680866 0.67 ALDH1A1 (0.60) ALDH1A1KDM4ESMN1; SMN2CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220202772-A1 COMPOSITIONS AND METHODS FOR INHIBITING RIBOSOME INACTIVATING PROTEINS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2022-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220202772-A1 COMPOSITIONS AND METHODS FOR INHIBITING RIBOSOME INACTIVATING PROTEINS RACK1, RRBP1, RPL30 ALDH1A1 3524/4885KDM4E 2155/4885SMN1; SMN2 430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.